- All > Medicine Information and Evidence for Policy > Information and Publications
- All > Medicine Information and Evidence for Policy > Medicines Policy
- Keywords > access to antiretroviral treatment
- Keywords > adherence to antiretroviral therapy
- Keywords > ARVs - sources and suppliers
- Keywords > christian health organizations
- Keywords > church health services
- Keywords > community-based organizations
- Keywords > Global Health Partnership (GHP)
- Keywords > HIV and AIDS programmes
- Keywords > HIV/AIDS
- Keywords > paediatric - HIV treatment
(2012; 17 pages) [French]
Have we learnt enough about stigma? Jesus was stigmatized, especially the closer he got towards his execution. Although the availability of antiretroviral medicines has increased over the last decade and HIV/AIDS is treated like many other chronic diseases, the stigma that infected people do experience is not overcome. Church leaders are highly respected and therefore are seen as a role model by their communities. How should we deal with people infected? All of us, if we claim to be faithful, should act as a role model and can make a difference to overcome stigma.
Christian health organizations give examples of being reliable partners for international organizations with huge HIV/AIDS programmes. CHAZ, CHAK and UCMB are excellent success stories to be reflected in this issue.
If we draw a balance of people receiving antiretroviral treatment and those without any medication, the situation is far from acceptable. The financial crisis affecting the funds for programmes is scary. Looking at the most vulnerable group of a society, the children, the lack of adequate medicines for them is even more shameful. Let us raise this issue, when we get in contact with donors and stakeholders.
A chronic disease requires continuous treatment. Adherence to antiretroviral therapy is key for keeping down the virus load in the patient. Every effective medicine can cause side effects. This applies also to antiretrovirals. The more a patient knows about the side effects to expect and what to do about it, the more likely she or he will still adhere to the medication. It is the responsibility of all personnel who are involved in the treatment and dispensing process to address this issue with the patient.
We know who is our role model, whom to follow. Isaiah 58, 7 reminds us what to do. We have medication to treat HIV/AIDS, we are involved in different roles in the health system and/or community. Let us be a role model!
In this issue:
- CHAZ HIV programmes: supporting humanity’s resilience
- Situation, market dynamics & challenges of paediatric ARV supply in sub-Saharan Africa
- The burden of HIV disease, key sources and suppliers of ARVs in selected Africa countries
- Adverse effects of ARVs – How to ensure treatment adherence
- Community-based treatment services - Patients’ health outcomes in 12 ACT facilities of the UCMB network
- HIV/Aids Care and Treatment – CHAK taking over an internationally manage programme
- Church leaders speak out on the Churches’ response to HIV in Kenya